Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 03 Mar 2026 for Intellia Therapeutics, Inc..
Filing timeline
BuySaleJames Basta
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
James Basta: trading record in brief
This profile gathers the share dealings of James Basta in Intellia Therapeutics, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 1 March 2022 to 2 March 2026, the count stands at 15 filings.
Every open-market trade on record is a sale: 8 sales worth €459k. Outside the open market, there are 7 share grants. So far in 2026, the count stands at no purchases and 2 sales.
Most recently, on 3 March 2026, the filings show an open-market sale worth €14k in Intellia Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Basta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
46,080 shares0Common StockSEC:0001193125-26-088260:0
10,397 shares@ US$9.2126.5% of flowCommon StockSEC:0001193125-26-006291:0
40,000 shares0Common StockSEC:0000950170-25-032086:0
7,074 shares@ US$12.1837.0% of flowCommon StockSEC:0000950170-25-003028:0
32,394 shares0Common StockSEC:0000950170-24-025906:0
3,805 shares@ US$29.4645.2% of flowCommon StockSEC:0000950170-24-002504:0
24,539 shares0Common StockSEC:0001209191-23-015722:0
1,138 shares@ US$37.2117.7% of flowCommon StockSEC:0001209191-23-002410:0
11,049 shares0Common StockSEC:0001209191-22-015909:0
9 of 9 declarations
